BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6283618)

  • 1. Solid-phase radioimmunoassays for Epstein-Barr virus associated antigens.
    Dölken G; Gier A; Finke J; Weitzmann U
    Ric Clin Lab; 1982; 12(1):307-12. PubMed ID: 6283618
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
    Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R
    J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the Epstein-Barr virus-associated antigens EA (early antigen) and VCA (viral capsid antigen) by direct or indirect binding of iodinated antibodies to antigen immobilized in polyacrylamide gel.
    Dölken G; Moar MH; Klein G
    Eur J Cancer (1965); 1979 May; 15(5):821-4. PubMed ID: 228942
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.
    Oldstone MB; Theofilopoulos AN; Gunvén P; Klein G
    Intervirology; 1974; 4(5):292-302. PubMed ID: 4377147
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of infective Epstein-Barr virus in a Burkitt lymphoma cell line, P3HR-1.
    Nagoya T; Hinuma Y
    Gan; 1972 Feb; 63(1):87-93. PubMed ID: 4339714
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of Epstein-Barr virus-determined intracellular antigens in unfixed cells with labeled antibodies.
    Hilgers F; Rosén A; Lamon E; Klein G
    J Natl Cancer Inst; 1974 Oct; 53(4):949-55. PubMed ID: 4372371
    [No Abstract]   [Full Text] [Related]  

  • 7. A practical and quantitative microtest for determination of neutralizing antibodies against Epstein-Barr virus.
    Rocchi G; Hewetson JF
    J Gen Virol; 1973 Mar; 18(3):385-91. PubMed ID: 4348798
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme immunoassay for detection of antibody to Epstein-Barr virus-specific early antigen.
    Garnlund DJ; Levine PH; Fuccillo DA
    J Clin Microbiol; 1979 Nov; 10(5):747-51. PubMed ID: 232507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies.
    Reedman BM; Klein G; Pope JH; Walters MK; Hilgers J; Singh S; Johansson B
    Int J Cancer; 1974 Jun; 13(6):755-63. PubMed ID: 4136722
    [No Abstract]   [Full Text] [Related]  

  • 11. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
    Wilson G; Miller G
    Virology; 1979 Jun; 95(2):351-8. PubMed ID: 223286
    [No Abstract]   [Full Text] [Related]  

  • 12. An immuno-electron microscopic analysis of Epstein-Barr virus-related antigens in Burkitt lymphoma cells.
    Suzuki I
    Gan; 1972 Oct; 63(5):629-31. PubMed ID: 4345632
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma.
    Sutherland JC; Olweny CL; Levine PH; Mardiney MR
    J Natl Cancer Inst; 1978 May; 60(5):941-6. PubMed ID: 205665
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies.
    Sternås L; Luka J; Kallin B; Rosén A; Henle W; Henle G; Klein G
    J Immunol Methods; 1983 Oct; 63(2):171-85. PubMed ID: 6311908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
    Ernberg I; Klein G; Kourilsky FM; Silvestre D
    J Natl Cancer Inst; 1974 Jul; 53(1):61-5. PubMed ID: 4365906
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigen expression and colony formation of lymphoblastoid cell lines after superinfection with Epstein-Barr virus.
    Rocchi G; Hewetson J; Henle W; Henle G
    J Natl Cancer Inst; 1973 Feb; 50(2):307-14. PubMed ID: 4349762
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on Epstein-Barr virus-associated antigens.
    Ernberg I
    Ann N Y Acad Sci; 1975 Jun; 254():516-22. PubMed ID: 170849
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion.
    Biggar RJ; Henle G; Böcker J; Lennette ET; Fleisher G; Henle W
    Int J Cancer; 1978 Sep; 22(3):244-50. PubMed ID: 212370
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the relation of membrane immunofluorescence to Epstein-Barr virus infection.
    Dunkel VC; Zeigel RF
    J Natl Cancer Inst; 1970 Jan; 44(1):133-44. PubMed ID: 11515024
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in frozen and thawed cells and subcellular fractions of human lymphoblastoid cell lines by means of an 125I-IgG binding assay.
    Brown TD; Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 1):351-6. PubMed ID: 190139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.